Effect of rapamycin nanoparticles in an animal model of primary biliary cholangitis

Figure 5 Nanoparticles encapsulating rapamycin treatment improved liver pathology. A: Comparison of the hepatic histopathological score between the two groups (^aP < 0.05); B: Hepatic histopathology visualized using hematoxylin and eosin staining in control mice; C: Hepatic pathological manifestations of mice in the treatment group. HE: Hematoxylin and eosin.